CoChat
Sign Up
Cited by 367SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesViral Infections and Outbreaks Research

Disappearance of Antibodies to SARS-Associated Coronavirus after Recovery

Open access
Cao, Wu-Chun, Liu, Wei, Zhang, Pan-He, Zhang, Fang, Richardus, Jan H.·2007·New England Journal of Medicine
DOI 10.1056/nejmc070348
Open this paper in CoChat — free account

Abstract

To the Editor: Previous studies have demonstrated that IgG and neutralizing antibodies against coronavirus associated with the severe acute respiratory syndrome (SARS) may persist, in spite of a de...

Integrity signals

Registry

Crossref · 10.1056/nejmc070348

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Natural history studies suggest that SARS-CoV and MERS-CoV infections, particularly mild illnesses, may not generate long-lived antibody responses.

    “This longitudinal assessment is relevant given that natural history studies suggest that SARS-CoV and MERS-CoV (Middle East respiratory syndrome coronavirus) infections, particularly mild illnesses, may not generate long-lived antibody responses.20-22”

    From An mRNA Vaccine against SARS-CoV-2 — Preliminary Report (2020) · cites this paper as [21]

The citation lists haven’t been fetched yet

References 5 · Cited by 367

Authors
Cao, W.-C., Liu, W., Zhang, P.-H., Zhang, F., & Richardus, J. H.
ORCID
Venue
New England Journal of Medicine
Publisher
Massachusetts Medical Society
Published
2007-09-13
Volume
357
Issue
11
Pages
1162-1163
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
DOI
10.1056/nejmc070348
OpenAlex
W2135926866
Cited by
367
References
5
Citations by year
2025: 1 · 2024: 15 · 2023: 20 · 2022: 55 · 2021: 119 · 2020: 132 · 2018: 3 · 2017: 2 · 2016: 3 · 2015: 1 · 2014: 1 · 2013: 3
FWCI
1.68
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
  • Health Sciences › Medicine › Infectious Diseases › Viral Infections and Outbreaks Research
Keywords
SARS-CoV, SARS, antibody persistence, neutralizing antibodies, IgG, antibody waning, recovery, humoral immunity
MeSH terms
Antibodies, Viral, Follow-Up Studies, Humans, Immunoglobulin G, Severe Acute Respiratory Syndrome, Severe acute respiratory syndrome-related coronavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review